Pyxis Total Current Assets from 2010 to 2024

PYXS Stock  USD 1.83  0.06  3.39%   
Pyxis Oncology Total Current Assets yearly trend continues to be comparatively stable with very little volatility. Total Current Assets are likely to outpace its year average in 2024. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2010-12-31
Previous Quarter
124.6 M
Current Value
135.9 M
Quarterly Volatility
81.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pyxis Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pyxis Oncology's main balance sheet or income statement drivers, such as Net Interest Income of 7.3 M, Interest Income of 7.3 M or Depreciation And Amortization of 2.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.6. Pyxis financial statements analysis is a perfect complement when working with Pyxis Oncology Valuation or Volatility modules.
  
Check out the analysis of Pyxis Oncology Correlation against competitors.
For more information on how to buy Pyxis Stock please use our How to Invest in Pyxis Oncology guide.

Latest Pyxis Oncology's Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Pyxis Oncology over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Pyxis Oncology's Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pyxis Oncology's overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

Pyxis Total Current Assets Regression Statistics

Arithmetic Mean62,059,631
Geometric Mean33,104,423
Coefficient Of Variation131.09
Mean Deviation63,672,392
Median19,701,000
Standard Deviation81,350,908
Sample Variance6618T
Range270.6M
R-Value0.64
Mean Square Error4174.3T
R-Squared0.41
Significance0.01
Slope11,708,597
Total Sum of Squares92651.6T

Pyxis Total Current Assets History

2024135.9 M
2023124.6 M
2022186.6 M
2021278.7 M
20208.1 M

About Pyxis Oncology Financial Statements

Pyxis Oncology shareholders use historical fundamental indicators, such as Total Current Assets, to determine how well the company is positioned to perform in the future. Although Pyxis Oncology investors may analyze each financial statement separately, they are all interrelated. The changes in Pyxis Oncology's assets and liabilities, for example, are also reflected in the revenues and expenses on on Pyxis Oncology's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Current Assets124.6 M135.9 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Pyxis Stock Analysis

When running Pyxis Oncology's price analysis, check to measure Pyxis Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pyxis Oncology is operating at the current time. Most of Pyxis Oncology's value examination focuses on studying past and present price action to predict the probability of Pyxis Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pyxis Oncology's price. Additionally, you may evaluate how the addition of Pyxis Oncology to your portfolios can decrease your overall portfolio volatility.